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Summary
Objective: Degeneration of articular cartilage leads to the development of osteoarthritis (OA), but the molecular pathology of the disease is
poorly understood. The Disproportionate micromelia (Dmm) mouse has a deletion mutation in the C-propeptide encoding region of Col2a1,
which leads to a defective cartilage matrix. The objective of this study was to determine whether heterozygous (Dmm/þ) mice develop pre-
mature OA, and could therefore serve as an animal model for studying the molecular pathways leading to OA.
Design: Histological analysis was utilized to determine the state of articular cartilage degeneration in Dmm/þ mice at 3, 6, 9, 12, 15, and 22
months of age. Severity of OA was quantiﬁed with a modiﬁed Mankin scoring system. In addition, articular cartilage thickness, cell density, and
the extracellular matrix (ECM) fraction of articular cartilage were quantiﬁed.
Results: Articular cartilage erosion was signiﬁcantly more severe in Dmm/þ than in wild-type (þ/þ) mice beginning at 9 months, and modiﬁed
Mankin scoring revealed Dmm/þ articular cartilage to be in a more severe osteoarthritic state as early as 3 months. In addition, Dmm/þ ar-
ticular cartilage was thinner than þ/þ cartilage and showed increased cell density and decreased matrix fraction compared with þ/þ from the
earliest time points measured.
Conclusions: The present study demonstrates that Dmm/þ mice develop premature OA. The observed degenerative changes of Dmm/þ ar-
ticular cartilage closely resemble those of human OA patients, with or without Col2a1 mutations, suggesting that Dmm/þ mice are a useful
model for investigating mechanisms involved in OA.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Key words: Disproportionate micromelia Dmm, Osteoarthritis, Articular cartilage, Cartilage erosion, Col2a1, Type II collagen.
International
Cartilage
Repair
SocietyIntroduction
Osteoarthritis (OA), characterized by painful degeneration
of articular cartilage and dysfunction of joints, affects 21 mil-
lion people in the United States alone and is a leading
cause of disability in this country1. Risk factors for the devel-
opment of OA include age, obesity, joint injuries, excessive
joint use, and hereditary conditions including malformed
joints and defective cartilage1. However, in spite of the large
number of people affected and the broad distribution of risk
factors in the population, the molecular pathogenesis of the
disease is not yet well understood. Therefore, there is a crit-
ical need for the development and study of appropriate and
convenient animal models of OA, both for expanding our
understanding of the disease and for developing and testing
new treatments.
Much of the animal research on OA performed to date
has utilized large animals such as dogs, rabbits, sheep,
and pigs in which OA results from surgical instability in-
duced by partial or total meniscectomy, by anterior cruciate
transaction, or by surgically applied damage2e4. OA has
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2005.477also been induced in large animals by intra-articular injec-
tion of iodoacetate or collagenase5,6. These large animal
models have yielded useful information about the progres-
sion of OA and have been utilized to test potential treat-
ments, but the difﬁculty of maintaining large research
animals makes such experiments impractical for the vast
majority of laboratories. Rodent models of OA are much
more useful and practical for most researchers.
A few mouse models of OA are currently available. One of
these, STR/ort, has been studied since the late 1970s7e9.
STR/ort mice spontaneously develop premature OA, with
manifestations including articular cartilage erosion, thicken-
ing of the subchondral bone, and widespread calciﬁcation
within the knee joints. Unfortunately, the genetic basis for
this predisposition to OA is not known. A second model,
Del1, was created by transgenically introducing a mutated
Col2a1 gene into the C57BL background10. The mutated
gene contains a 45 bp deletion within the triple helical coding
region, and its overexpression causes subchondral bone
sclerosis, cartilage erosion, fragmented menisci, and osteo-
phyte formation11. A third model, the chondrodysplasia (cho)
mouse, contains a single nucleotide deletion mutation in the
Col11a1 gene, which leads to a premature stop codon12.
This naturally occurring mutation causes premature onset
OA as evidenced by chondrocyte clustering, proteoglycan
loss, and degradation of type II collagen at the articular
surface13,14.
We demonstrate herein that the murine line called Dispro-
portionate micromelia (Dmm) can also serve as a useful
new animal model of OA. Research begun in the early
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mice display severe skeletal dysplasia and cleft palate sec-
ondary to micrognathic tongue obstruction, and die shortly
after birth due to pulmonary hypoplasia caused by rib skel-
etal dysplasia15e17. Heterozygotes (Dmm/þ), in contrast,
appear normal at birth and exhibit only mild dwarﬁsm begin-
ning at approximately 1 week postpartum15.
The Dmmmutation is a three-nucleotide deletion in the C-
propeptide coding region of theCol2a1 gene, which replaces
lysineand threoninewith asparagine (KT206,207N) in ahighly
conserved region of the protein18. Although the C-propeptide
region is not part of the mature type II collagen molecule, it
plays an important role in collagen trimer assembly. After
proa1(II) chains, coded by the Col2a1 gene, are translated
and secreted into the rough endoplasmic reticulum (RER),
the C-propeptides associate via hydrophobic and electro-
static interactions, with assistance from speciﬁc protein
chaperones19,20. Subsequently, intra- and interchain disul-
ﬁde bonds form that help stabilize the homotrimer during
folding of the triple helical domains21,22. Once folding is ac-
complished, proa1(II) trimers are transported to the extracel-
lular matrix (ECM) where their N- and C-propeptides are
enzymatically cleaved and the triple helical domains are in-
corporated and cross-linked into the heterotypic ﬁbers21. In
theDmmmouse, the C-propeptidemutation prevents normal
collagen processing, resulting in the accumulation of type II
collagen intracellularly, with a corresponding deﬁciency of
this protein in the cartilage ECM23.
Similar mutations in the human COL2A1 gene have been
shown to cause a variety of disease phenotypes in cartilage24.
Although the majority of identiﬁed COL2A1 mutations disrupt
the repetitive Gly-X-Y pattern of amino acids in the triple
helical domain, ﬁve disease-causing mutations have been
identiﬁed in the C-propeptide coding region of COL2A1.
They all cause phenotypically overlapping chondrodyspla-
sias: Stickler syndrome25, vitreoretinopathy with phalangeal
epiphyseal dysplasia26, spondyloperipheral dysplasia, achon-
drogenesis II e hypochondrogenesis, and spondyloepiphy-
seal dysplasia25e29. Furthermore, all are associated with
degeneration of the articular cartilage. As in Dmm mice, the
C-propeptide mutations are presumed to cause disease
phenotypes by producing chains that disrupt the assembly
and/or secretion of triple helical procollagen molecules18,23.
The phenotypic similarities between the human COL2A1
C-propeptide mutations and the Dmm mutation suggested
that the Dmm mouse would be a useful model for the study
of OA. We present here a thorough histological analysis of
articular cartilage abnormalities in Dmm/þ mice and dem-
onstrate that these mice do, in fact, display most of the his-
tological hallmarks of OA including articular cartilage
thinning and degeneration, proteoglycan loss, increased
cell density, and decreased ECM. The Dmm/þ mouse,
therefore, has potential as a new model of OA for the study
of disease progression and for the development and testing
of OA treatments.
Methods
FACILITIES, EXPERIMENTAL ANIMALS, AND GENOTYPING
The animals used in this study were maintained in the an-
imal care facility of Brigham Young University. Mice were
kept in paper-bedded, 5.7 L cages, fed a typical mouse
diet, and provided with a 12-h-light/12-h-dark cycle.
Heterozygous mice (Dmm/þ) on a C3H strain back-
ground were crossed to produce the wild-type (þ/þ) and
Dmm/þ mice used in this study. Approximately 1 monthpostpartum, the pups were isolated from the dam and as-
signed a number, and marks representing each number
were punched into each animal’s ears for identiﬁcation
throughout the study. Tail samples were obtained at this
time for use in genotyping.
DNA was isolated from the tail samples, and polymerase
chain reaction (PCR) ampliﬁcation was performed with
primers ﬂanking the mutation site, followed by restriction
enzyme digestion with BcgI, a restriction enzyme that rec-
ognizes the mutated nucleotide sequence but not the
wild-type sequence18. Restriction fragments were separated
on a 1% agarose gel containing ethidium bromide and
viewed with a UV transilluminator.
TISSUE PROCESSING
Mice of each genotype at various ages (3, 6, 9, 12, 15, and
22months) were weighed, asphyxiatedwith CO2, and the left
knee joint was removed from eachmouse. These joints were
ﬁxed in periodateelysineeparaformaldehyde, decalciﬁed in
formic acid, and embedded in parafﬁn. Parafﬁn blocks con-
taining the joints were then prepared with each knee bent
at a 120( angle, the tibia parallel to the sectioning surface,
and the femur obliquely perpendicular to the sectioning sur-
face. These tissue blocks were cut into 6-mm-thick serial sec-
tions through the entire joint, starting at the anterior surface,
thereby yielding six 210-mm-thick strata [Fig. 1(A)]. With the
tissue thus oriented in the blocks, we were able to examine
each quadrant of the knee joint in the coronal section
[Fig. 1(B)], including medial and lateral tibial plateaus and
medial and lateral femoral condyles. One slide from each
stratum was stained with hematoxylin and eosin and another
was stained with safranin O and fast green. Hematoxylin and
eosin-stained tissue was analyzed to determine articular car-
tilage thickness [Fig. 1(C)] and the extent of cartilage erosion
(Table I). The fast green and safranin O-stained tissue was
used to assess the osteoarthritic state of the cartilage using
a modiﬁed Mankin scoring system (Table I).
Additional left knee joints from 3- and 6-month mice were
ﬁxed in 3% glutaraldehyde in 0.1 M phosphate buffer, de-
calciﬁed in L-ascorbic acid, bisected sagittally through the
patellar notch, postﬁxed in 1% osmium tetroxide, and em-
bedded in Spurr’s Low Viscosity Embedding Resin. The
medial portion of each joint was oriented with the cut sur-
face parallel to the sectioning surface of the block, oriented
such as to yield sagittal sections. Each plastic block was cut
into 1-mm-thick sagittal sections and stained with toluidine
blue/azure II solution. These tissue sections were used to
determine cell density and to estimate the matrix fraction
of articular cartilage. All slides containing stained sections
were viewed and photographed under an Olympus BX51
light microscope attached to a computer-operated Spot
RT digital color camera.
QUANTIFICATION OF EROSION AND THICKNESS
OF ARTICULAR CARTILAGE
Hematoxylin and eosin-stained tissue was examined un-
der the microscope and an erosion score was determined
for each quadrant of each stratum of each joint, depending
on how deep the erosion extended into the cartilage1,11,30.
Scores were assigned as shown in Table I. With this scoring
system, a higher erosion score corresponded to more se-
vere OA. The average erosion score for each joint was
then calculated.
Sections from each stratum of each knee joint were photo-
graphed and the digital images were analyzed using Adobe
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shop’s selection tools were used to select an area that
spanned 500 mm across the surface of the cartilage and
extended down to the surface of the subchondral bone
[Fig. 1(C)]. The number of pixels in the selected area was
noted in Photoshop’s histogram window. This value was
then converted to mm2 and divided by 500 mm to provide
an estimate of the average overall thickness of the cartilage
(measured from cartilage surface to the subchondral bone)
within the selected area. This procedure was also used to de-
termine the average thickness of uncalciﬁed cartilage, in
which the area selected extended down to the tidemark.
We then mathematically determined the thickness of calci-
ﬁed cartilage. This procedure was done for each quadrant
of each stratum of each joint.
DETERMINATION OF OA SEVERITY
Safranin O and fast green-stained tissue was examined
under the microscope and scores were assigned based
on three criteria: interterritorial matrix staining (IMS) of un-
calciﬁed cartilage with safranin O, pericellular matrix stain-
ing (PMS) with safranin O, and spatial arrangement of
chondrocytes (SAC). Scores for each of these three criteria
Fig. 1. (A and B) Schematic representation of left knee joints show-
ing the divisions used in this study. (A) Lateral view. Vertical lines
represent the borders between each of the strata. (B) Anterior
view. Black lines indicate borders between each of the quadrants.
(C) Illustration of the method by which cartilage thickness was quan-
tiﬁed. AdobePhotoshop’s selection tools were used to select an area
that spanned 500 mmacross the surface of the cartilage and extended
down to the surface of the subchondral bone. The selected area is
shown within the thin black line. The number of pixels within the
area was converted to mm2 and this value was divided by 500 mm
to estimate the average cartilage thickness within the selected
area. BM, bone marrow; SCB, subchondral bone; CC, calciﬁed
cartilage; TM, time mark; UCC, uncalciﬁed cartilage; M, meniscus.were assigned as shown in Table I. The assigned sub-
scores from each of these criteria were summed to deter-
mine the modiﬁed Mankin score for each quadrant of
each stratum of each knee joint 1,14,30. With this technique,
a higher score indicates a more severe state of OA. The av-
erage score for each joint was then calculated.
DETERMINATION OF CELL DENSITY AND MATRIX FRACTION
Toluidine blue/azure II stained tissue was photographed,
and the digital images were analyzed using Adobe Photo-
shop 7.0 (Adobe Systems, San Jose, CA). An area that
spanned 1 mm across the surface of the medial femoral car-
tilage and extending through the depth of the cartilage bor-
dering the subchondral bone was selected, and the size of
this area was determined. The cells within the area were
then counted to estimate cell density, and the area occupied
by these cells was subtracted from the total area to deter-
mine the matrix fraction of the selected tissue ﬁeld.
STATISTICAL ANALYSIS
A two-way analysis of variance (ANOVA) was used to
compare the means of Dmm/þ data from the entire joint
(erosion scores, total cartilage thickness, cell density,
matrix fraction, and modiﬁed Mankin scores) in relation to
age, with the means of þ/þ data. Student’s t test was
used to compare the means of calciﬁed cartilage thickness,
uncalciﬁed cartilage thickness, IMS sub-scores, PMS sub-
scores, and SAC sub-scores from Dmm/þ cartilage with
those of age-matched þ/þ cartilage.
Results
EROSION OF DMM/þ CARTILAGE
Inspection of þ/þ knee joints showed healthy articular
cartilage with little or no erosion through 22 months
(Fig. 2). Dmm/þ knee joints revealed erosion of uncalci-
ﬁed cartilage by 6 months of age and erosion to the
Table I
Scoring systems used to evaluate articular cartilage of mice
Feature Score
Cartilage erosion scoring system
Smooth noneroded cartilage 0
Rough noneroded cartilage 1
Superﬁcial ﬁbrillation 2
Separation of uncalciﬁed from calciﬁed cartilage 3
Erosion of uncalciﬁed cartilage only 4
Erosion extending into calciﬁed cartilage 5
Erosion down to the subchondral bone 6
Modiﬁed Mankin scoring system
PMS
Normal intensity 0
Focal points of enhanced intensity 1
More than 40% of cartilage with enhanced staining 2
SAC
Normal 0
Diffuse hypercellularity 1
Focal points of hypocellularity 2
Diffuse hypocellularity 3
IMS
Normal staining 0
Reduced staining 1
Focal points without any staining 2
More than 40% of cartilage without any staining 3
480 B. D. Bomsta et al.: Premature OA in the Dmm mouseFig. 2. Dmm/þ cartilage exhibited premature articular cartilage erosion. Images shown are low magniﬁcation (bar¼ 100 mm) light micrographs
of medial knee joint cartilage. Numbers on the left side of the þ/þ column indicate ages (months) of the mice. Knee joints from þ/þ mice
showed no irregularities in the cartilage until 15 months, when only superﬁcial irregularities were seen. Dmm/þ joints showed erosion (arrows)
of uncalciﬁed cartilage as early as 6 months, and severity of erosion increased with age, eventually leading to complete loss of all cartilage.
Quantiﬁcation of cartilage erosion (lower panel) using the scoring system outlined in Table I revealed that average cartilage erosion in Dmm/þ
articular cartilage is signiﬁcantly greater than in þ/þ. N¼ 4 at each age and genotype, except N¼ 5 for 3-month þ/þ and 3-month Dmm/þ.
*P< 0.05.
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gree of cartilage erosions using the scoring system shown
in Table I conﬁrmed that erosion of þ/þ cartilage was
minimal through 12 months and only slight increases
were seen thereafter (Fig. 2). In contrast, erosion of
Dmm/þ cartilage was evident in young mice and pro-
gressed steadily throughout adulthood, with signiﬁcantly
more erosion than in þ/þ cartilage starting at 9 months
of age.CARTILAGE THINNING IN DMM/þ MICE
Under low magniﬁcation, the þ/þ knee joints showed
healthy cartilage with columnar arrays of chondrocytes
and abundant ECM. Dmm/þ knee cartilage appeared thin-
ner than þ/þ cartilage and also displayed a lack of colum-
nar organization of chondrocytes and a diminished amount
of ECM between cells [Fig. 3(A)]. Quantiﬁcation of total car-
tilage thickness revealed that Dmm/þ cartilage was signiﬁ-
cantly thinner than þ/þ cartilage at all ages [Fig. 3(B)]. TheFig. 3. Articular cartilage in Dmm/þ knee joints exhibited decreased thickness and disorganized arrangement of cells. (A) High magniﬁcation
(bar¼ 50 mm) light micrographs of 6-month knee joints stained with hematoxylin and eosin revealed that þ/þ articular cartilage had columnar
arrays of chondrocytes while Dmm/þ cartilage was thinner than þ/þ cartilage, lacked columnar organization of chondrocytes, and showed
increased cell density. (B) Quantiﬁcation of the average cartilage thickness revealed that Dmm/þ articular cartilage is signiﬁcantly reduced
relative to þ/þ at every age examined. Left bar of each age group represents þ/þ, and right bar of each age group represents Dmm/þ. Error
bars and asterisks above the bar are for total cartilage thickness. Asterisks in the calciﬁed or uncalciﬁed portion of the bar are for the corre-
sponding portion of the cartilage. N¼ 4 at each age and genotype, except N¼ 5 for 3-month þ/þ and 3-month Dmm/þ. *P< 0.05.
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than in þ/þ at all ages, as was uncalciﬁed cartilage at all
ages except 6 and 12 months.
INCREASED OA SCORING IN DMM/þ MICE
Safranin O is a cationic stain with a high afﬁnity for neg-
atively charged proteoglycan. In the modiﬁed Mankin scor-
ing system for OA severity utilized here (Table I), reduced
IMS by safranin O is indicative of proteoglycan deﬁciency.
Furthermore, enhanced PMS suggests that chondrocytes
have increased production and secretion of proteoglycan
in response to proteoglycan degradation. Scoring of the
spatial arrangement of cells is designed to detect disorga-
nized chondrocyte proliferation, in early stages of OA, as
well as cell death, in late stages of OA.
Fast green and safranin O-stained þ/þ cartilage generally
revealed evenly stained interterritorial matrix with normal
levels of pericellular staining and columnar organization of
chondrocytes [Fig. 4(A)]. In contrast, Dmm/þ cartilage fre-
quently revealed regions of the interterritorial matrix with little
or no proteoglycan staining, while also displaying enhanced
staining of the pericellular matrix. The lack of organization
and increased density of chondrocytes in Dmm/þ cartilage
were also apparent in these sections. Modiﬁed Mankin scor-
ing of these characteristics conﬁrmed that Dmm/þ cartilage
was in a more osteoarthritic state than þ/þ at every age
examined [Fig. 4(B)]. Furthermore, Dmm/þ cartilage hada signiﬁcantly larger sub-score for each of the criteria (IMS,
PMS, and spatial arrangement of cells) in virtually every
age group when compared with þ/þ.
The IMS sub-scores from Dmm/þ cartilage revealed that
proteoglycan deﬁciency was present at 3 months. Interest-
ingly, however, this proteoglycan deﬁciency did not seem to
increase with age [Fig. 4(B)]. The PMS sub-scores showed
that Dmm/þ cartilage had areas of enhanced proteoglycan
production as early as 3 months, which increased in size
with age. A similar pattern of enhanced proteoglycan pro-
duction was seen in þ/þ cartilage, but not until later in
life. The sub-scores for spatial arrangement of cells in
Dmm/þ tissue revealed that cartilage was already hypercel-
lular in 3-month animals, and this hypercellularity persisted
until about 15 months when regions of the cartilage became
hypocellular. In comparison, þ/þ cartilage showed only
slight hypercellularity in older animals.
INCREASED CELL DENSITY AND REDUCED MATRIX FRACTION
IN DMM CARTILAGE
Histological sections of resin-embedded þ/þ cartilage
stained with toluidine blue/azure II showed moderate cell
density near the surface of the cartilage and decreased cell
density in deeper layers [Fig. 5(A)]. Dmm/þ appeared to
have a greater cell density than þ/þ near the surface of the
cartilage and through the entire depth of the cartilage, and
also appeared to have a reduced amount of ECM whenFig. 4. Safranin O staining in Dmm/þ cartilage revealed regions of decreased proteoglycan staining in the interterritorial matrix and increased
proteoglycan staining in the pericellular matrix. (A) Images shown are high magniﬁcation (bar¼ 50 mm) light micrographs of 9-month medial
tibial cartilage, stained with fast green and safranin O. The þ/þ cartilage displayed evenly stained interterritorial matrix with normal levels of
pericellular staining and columnar organization of chondrocytes. In contrast, Dmm/þ cartilage contained regions of interterritorial matrix with
little or no proteoglycan staining (black arrows), combined with enhanced staining of the pericellular matrix (blue arrows) and densely packed,
disorganized chondrocytes. (B) Modiﬁed Mankin scoring revealed signiﬁcantly more severe OA in Dmm/þ relative to þ/þ cartilage. Left bar of
each age group represents þ/þ, and right bar of each age group represents Dmm/þ. Error bars and asterisks above the bar are for total score.
Asterisks in the IMS, PMS, or SAC portion of the bar are for the corresponding sub-score. N¼ 4 at each age and genotype, except N¼ 5 for
3-month þ/þ and 3-month Dmm/þ. *Signiﬁcantly greater than þ/þ (P< 0.05).
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vealed that Dmm/þ mice have signiﬁcantly more cells per
unit area thanþ/þ [Fig. 5(B)]. The matrix fraction ofþ/þ car-
tilage was found to be 89.2%, whereas the matrix fraction of
Dmm/þ cartilage was signiﬁcantly less at 75.5% [Fig. 5(C)].
Discussion
This work has revealed that Dmm/þ mice display abnor-
malities in articular cartilage even at very young ages and
before overt cartilage degeneration becomes apparent,
presumably due to the role the Dmm mutation plays during
cartilage development. These abnormalities include hyper-
cellularity and decreased ECM fraction, which predispose
the animals to severe premature articular cartilage
degeneration.
The changes observed in Dmm/þ cartilage are consistent
with a widely accepted three-stagemodel for the progression
of OA. In the ﬁrst stage, macromolecules in the ECM are de-
graded. Aggrecan, the major proteoglycan of cartilage, is
cleaved by aggrecanases, and type II collagen, the major
Fig. 5. Dmm/þ cartilage had increased cell density and decreased
matrix fraction. (A) High magniﬁcation (bar¼ 50 mm) light micro-
graphs of 3-month medial femoral cartilage stained with toluidine
blue and azure II. Cartilage from þ/þ mice showed moderate cell
density near the surface of the cartilage and decreased cell density
in deeper layers. Dmm/þ, in contrast, showed increased cell density
throughout the entire depth of the cartilage and a correspondingly
reduced matrix fraction. (B) Cell counts showed 53% more cells per
unit area in Dmm/þ than þ/þ cartilage, even though Dmm/þ cells
appeared to be larger (*P< 0.01). (C) Quantiﬁcation of the relative
area covered by cells vs ECM per unit area showed that Dmm/þ
cartilage had a signiﬁcantly decreased matrix fraction relative to
þ/þ cartilage. N¼ 2 for 3-month þ/þ and Dmm/þ, and for 6-month
þ/þ. N¼ 3 for 6-month Dmm/þ. (*P< 0.01).component of collagen ﬁbrils, is cleaved by matrix metallo-
proteases31e34. The diminished matrix fraction observed in
young Dmm/þ animals could result from such early-stage
degradation of matrix molecules, but it more likely results
from the decreased export of type II collagen, and perhaps
other matrix macromolecules, from chondrocytes during
the development of articular cartilage. Such decreased ex-
port of matrix molecules during development would result
in the generation of signiﬁcantly thinner articular cartilage
in Dmm/þ relative to þ/þ animals, with decreased ECM
and increased crowding of the chondrocytes as was ob-
served from the earliest time points measured. This thinness
could in turn compromise the cartilage’s ability to disperse
compressive forces, thus increasing stress on the chondro-
cytes and evoking a chondrocytic inﬂammatory response, in-
cluding the release of inﬂammatory cytokines known to
promote the degradation of ECMmacromolecules1,35,36. Ac-
cordingly, Dmm/þ mice as young as 3 months show signiﬁ-
cantly reduced proteoglycan staining in the interterritorial
matrix relative to þ/þ mice.
In the second stage of OA, chondrocytes attempt to re-
place the degraded ECM molecules by activating prolifera-
tive pathways as well as by increasing synthesis of new
ECM macromolecules1,37. The increased proliferation pro-
duces cell clustering and hypercellularity, and the increased
synthesis of ECM macromolecules produces concentrated
proteoglycans in the immediate vicinity of the cell known
as the pericellular matrix. In Dmm/þ mice, diffuse regions
of cell clustering together with increased proteoglycan stain-
ing in the pericellular matrix were apparent and signiﬁcantly
different from þ/þ as early as 3 months.
In the third stage of OA, irregularities initially appear as
localized ﬁbrillations in the superﬁcial layer of articular car-
tilage. These abnormalities progress into deeper layers of
the tissue, eventually leading to erosion of the cartilage.
During the later stages of the disease, the chondrocytes’
anabolic and proliferative responses are shut down. This,
coupled with cell death, leads to hypocellularity of the tis-
sue1. Erosion likely continues until cartilage is completely
lost from articulating surfaces and the joint is left with only
bone on bone interactions1. The majority of Dmm/þ mice
progress into this third stage by 9 months, and the cartilage
erosion becomes more and more severe over time. Several
of the older Dmm/þ animals in this study displayed regions
of erosion into and through the calciﬁed cartilage, resulting
in the exposure of subchondral bone. The þ/þ mice, in con-
trast, rarely displayed any lesions worse than a roughening
of the articular surface, even at 22 months.
It is interesting to note the severity of this OA phenotype
in Dmm/þ animals, in spite of the fact that they also exhibit
decreased body weight. (Our unpublished observations
show that Dmm/þ mice weigh approximately 17% less
than þ/þ mice, on average.) This is in contrast to the
case in humans, where increased body mass is thought
to contribute to the development of OA. The more favor-
able weight-bearing conditions in Dmm/þ mice relative to
þ/þ mice are clearly not sufﬁcient to counteract the effects
of the Dmm mutation and the resulting cartilage defect,
a situation that has parallels with some human OA
sufferers.
Other parallels between Dmm/þ, human OA, and other
mouse models of OA are apparent. For example, in both
Dmm/þ and STR/ort mice, the medial side of the knee joint
exhibits more severe cartilage erosion than the lateral
side38. This is presumably due to a joint structure that pla-
ces more of the stress of walking on the medial portion of
the joint. In humans, joint structure that results in the
484 B. D. Bomsta et al.: Premature OA in the Dmm mouseuneven distribution of joint pressure also results in a predis-
position to OA at the site of increased pressure1.
In summary, human and Dmm OA tend to follow the
three-stage progression outlined above, whether the OA
is triggered by different genetic mutations, structural abnor-
malities, increased body mass, or other factors. The genetic
basis for most human OA cases is unknown, but this simi-
larity in the disease progression suggests that OA may fol-
low a common pathway of molecular pathogenesis
regardless of its initial trigger. This in turn suggests that
much can be learned about human OA from the Dmm model,
even though the majority of human OA cases are not
caused by COL2A1 mutations. Continuous study of Dmm
mice in relation to other models and to human cases will re-
veal whether this common pathogenetic pathway hypothe-
sis is correct. In the meantime, however, we conclude that
the work presented here establishes Dmm mice as an ap-
propriate model for studying OA disease progression and
for testing potential treatments.
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